Isavuconazole Impurity 53

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB2733698172
CAS	2733698-17-2
Molecular Weight	279.3
Molecular Formula	C13H17N3O4

What is the specific name of the impurity with CAS number 2733698-17-2?

The specific name of the impurity is Isavuconazole Impurity 53.

What is the molecular weight of Isavuconazole Impurity 53?

The molecular weight of Isavuconazole Impurity 53 is 279.3.

What is the chemical formula of Isavuconazole Impurity 53?

The chemical formula of Isavuconazole Impurity 53 is C13H17N3O4.

What is the significance of Isavuconazole Impurity 53 in the context of pharmaceuticals?

Isavuconazole Impurity 53 is important in pharmaceuticals as it is an impurity that needs to be monitored and controlled in the production of isavuconazole.

How is Isavuconazole Impurity 53 commonly detected or analyzed in pharmaceutical manufacturing?

Isavuconazole Impurity 53 is commonly detected or analyzed using analytical techniques such as HPLC (High Performance Liquid Chromatography) and spectroscopy.

What are the potential effects of Isavuconazole Impurity 53 on the quality and efficacy of isavuconazole products?

Isavuconazole Impurity 53 can potentially impact the quality and efficacy of isavuconazole products by affecting purity, stability, and potential side effects.

Why is it important to control the levels of Isavuconazole Impurity 53 in pharmaceutical formulations?

It is important to control the levels of Isavuconazole Impurity 53 in pharmaceutical formulations to ensure the safety, quality, and efficacy of the final product.

How can the presence of Isavuconazole Impurity 53 be minimized during the manufacturing process?

The presence of Isavuconazole Impurity 53 can be minimized during the manufacturing process by optimizing synthesis conditions, purification techniques, and analytical monitoring.

Are there any regulatory guidelines or limits for Isavuconazole Impurity 53 in pharmaceutical products?

Yes, regulatory guidelines and limits exist for Isavuconazole Impurity 53 in pharmaceutical products to ensure compliance with safety and quality standards.

What steps can pharmaceutical companies take to develop robust methods for monitoring and controlling Isavuconazole Impurity 53?

Pharmaceutical companies can develop robust methods for monitoring and controlling Isavuconazole Impurity 53 by conducting thorough characterization studies, validation of analytical methods, and continuous monitoring of impurity levels.

* Products or Services Interested: Isavuconazole Impurity 53 (2733698-17-2)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry